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Abstract Cyanobacterial blooms are undesirable for ecolog-
ical and health reasons. While Woronichinia naegeliana is a
cyanobacterial species that appears frequently in freshwater,
information about it is limited. An evaluation of its toxicity
was conducted via tests based on the crustaceans
Thamnocephalus platyurus and Daphnia pulex. The greatest
effect of the aqueous extract obtained from W. naegeliana
cells was observed for T. platyurus. The denoted semi-lethal
concentration (LC50) after 24 h of exposure was 0.99 mg of
dry weight (d.w.) mL−1. A lower toxicity was displayed for
D. pulex, although it grew with time. Among the 18 fractions
separated from cyanobacterial extract, only one containing the
microginin FR3 (MG-FR3) displayed biological activeness
against T. platyurus. The remaining products synthesized by
W. naegeliana displayed an absence or a low level of toxicity
making it impossible to determine the LC50 value. Detailed
research revealed that MG-FR3 did not affect the activity of
enzymes such as trypsin, chymotrypsin, elastase and throm-
bin, which indicates another mode of action. The results dem-
onstrated that blooms of W. naegeliana showed toxic activity
towards invertebrate zooplankton.
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Introduction
The intensification of cyanobacterial mass occurrences in var-
ious aquatic environments is observed worldwide.
Cyanobacterial blooms are serious problems, particularly for
reservoirs that are a source for potable water. Cyanobacteria
are known for the production of a wide range of secondary
metabolites of various structure and biological activity.
Among them are compounds affecting the taste and odour of
water (e.g. 2-methylisoborneol [MIB] and geosmin), toxins
(e.g. alkaloids, cyclic peptides) and oligopeptides, whose bio-
logical function is unclear (see references in Smith et al.
2008). Although cyanobacteria are capable of simultaneous
synthesis of several compounds, only a few are dominant.
Generally, cyanobacteria are recognized as toxic if they pos-
sess the ability to produce neurotoxins (e.g. anatoxin-a),
dermatotoxins (e.g. aplysiatoxin) or hepatotoxins (e.g.
microcystins) (Burkholder and Gilbert 2006). This classifica-
tion does not concern the synthesis of some oligopeptides that
contain unusual amino acids in their structures and are con-
sidered ‘non-toxic’, although some of them have been recog-
nized as protease inhibitors. The strong inhibitory activity of
cyanobacterial peptides against animal digestive proteases
(e.g. elastase, chymotrypsin, trypsin) might indicate their
function as anti-grazing factors, whereas the inhibition of
thrombin activity, final coagulation protease, might be useful
from a medical point of view in designing of new drugs (see
references in Chlipala et al. 2011).
The monitoring of potential threats caused by cyanobacterial
blooms relies on confirmation of the presence of toxins using
mostly analytical methods. However, the application of chemi-
cal methods is often complicated due to the lack of appropriate
equipment, operational procedures or commercially available
standards for compounds. In addition, based only on the results
obtained from chemical analyses, it is difficult to exclude the
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synergic effects of several toxic and non-toxic compounds re-
leased by cyanobacteria. Jungmann (1992) showed that fractions
isolated from the extract ofMicrocystis aeruginosa cells that did
not contain hepatotoxic microcystin-LR appeared to be more
toxic to Daphnia sp. than those containing the compound.
These may be the most probable reasons why an application
of bioassays for evaluation of the bioactivity of all secondary
metabolites synthesized by cyanobacteria increases in time.
Additionally, relatively simple procedures keep the costs of these
routinely performed analyses relatively low (Törökné et al.
2007).
Out of all the cyanobacterial species commonly occurring
in water reservoirs, the most widely characterized are those
frequently described as toxic (Sivonen and Jones 1999).
Although blooms of the cyanobacterium Woronichinia
naegeliana belonging to the Chroococcales also appear more
frequently in the phytoplankton of freshwater worldwide; in-
formation about this species is limited. This is likely due to
difficulties in the cultivation of this species under laboratory
conditions (Rajaniemi-Wacklin et al. 2005). Bober et al.
(2011) reported determination of compounds produced by
W. naegeliana. The majority of its identified secondary me-
tabolites belong to three classes of oligopeptides: microginins,
cyanopeptolins and anabaenopeptins. The extract also
contained trace amounts of microcystin-LR. Some studies of
W. naegeliana report contradictory data about its toxicity
(Rajaniemi–Wacklin et al. 2005, Willame et al. 2005,
Baudin et al. 2006, Oberholster et al. 2006). However, in these
studies, the main criteria for cyanobacterial biological activity
were the presence of microcystins or genes responsible for its
production.
Due to potentially significant consequences following the
occurrence of W. naegeliana blooms in freshwater and the lim-
ited information about its biological activity, this study has been
undertaken to determine its toxicity. The toxicity tests used here
were based on the crustaceans Thamnocephalus platyurus and
Daphnia pulex. These assays are commonly used to evaluate the
toxicity of many compounds and are particularly sensitive to
cyanobacterial toxins. In addition, assays on separated fractions
isolated from cyanobacterial cell extract were performed to de-
termine which compounds are responsible for the biological
response. More detailed research including various protease in-
hibition assays was conducted on the microginin FR3, the dom-
inant compound synthesized byW. naegeliana.
Material and methods
Cyanobacteria
Woronichinia naegeliana (Unger) Elenkin was collected from
Dobczyce reservoir in southern Poland in September 2013.
Identification and isolation were done according to Bober
et al. (2011).
Sample preparation
The cell material was lyophilized and divided into two por-
tions of 1 g dry weight (d.w.) each. One portion was extracted
with 100 mL Milli-Q water and then filtered through GF/C
glass-fibre filters (Whatman, UK). The second portion was
used for separation of crude cell extract into fractions contain-
ing secondary metabolites according to the procedure de-
scribed previously (Bober et al. 2011). Briefly, lyophilized
cells were extracted with 100 mL 100% methanol under con-
stant shaking and then filtered through a GF/C filter. After
evaporation to dryness in a nitrogen atmosphere at room tem-
perature, the sample was dissolved in 100 mL Milli-Q water
and concentrated by solid phase extraction with a C18 silica
cartridge (Baker Bond, USA). The cartridge was conditioned
with 10 mL 100% methanol followed by 10 mL methanol:
10% acetic acid (4:1 v/v). The aqueous sample was passed
through at 5 mL min−1 flow rate. The cartridge was then
washed with 10 mL portions of 10, 20 and 30% methanol.
The eluate, obtained using 10 mL 80% methanol, was evapo-
rated to dryness in a nitrogen atmosphere at room temperature
and dissolved in 1 mL Milli-Q water for analysis using a
Waters Inc. (USA) high-performance liquid chromatography
system containing a 600E gradient pump, 717 plus
autosampler, a Jetstream 2 plus column thermostat, 996 pho-
todiode array detector and Millenium32 SS Software with
PDA option. Separation of extract was achieved using a
Symmetry C18 column (4.6 × 250 mm; 5 μm; Waters, USA)
maintained at 23 °C and gradient mobile phases consisting of
(a) water/trifluoroacetic acid (0.05%, v/v) and (b) acetonitrile/
trifluoroacetic acid (0.05%, v/v). The elution gradient was
changed from 70 to 35% of eluent A over 35 min at a flow
rate 0.7 mL min−1. Chromatograms were monitored at
220 nm. The fractions separated were evaporated to dryness
in a nitrogen atmosphere at room temperature and diluted with
Milli-Q water to the volume of the extract that was separated;
therefore, their concentrations were equivalent to
W. naegelina biomass concentration. The fractions were
analysed using the ULPC-MS/MS system consisting of a
Waters ACQUITY UPLC (Waters Inc., USA) coupled with
a Waters TQD mass spectrometer (electrospray ionization
mode ESI-tandem quadrupole). Chromatographic analyses
were performed using the Acquity UPLC BEH (bridged ethyl
hybrid) C18 column (2.1 × 100 mm; 1.7 μm) equipped with
the Acquity UPLC BEH C18 VanGuard pre-column
(2.1 × 5 mm; 1.7 μm). The column was maintained at 40 °C
and eluted using mobile phases consisting of (a) water/formic
acid (0.1%, v/v) and (b) acetonitrile/formic acid (0.1%, v/v).
Gradient conditions changed from 95 to 0% of eluent A over
10 min at a flow rate of 0.3 mL min−1. The MS operational
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conditions were as follows: source temperature of 150 °C,
desolvation temperature of 350 °C, desolvation gas flow rate
of 600 L h−1, cone gas flow of 100 L h−1, capillary potential of
3.00 kV and cone potential of 20 V. Nitrogen was used for
both the nebulizing and drying gas. The data were obtained in
a scanmode ranging from 50 to 2000m/z. Target ions selected
for MS/MS analyses were fragmented with a collision-
activated dissociation energy of 40 eV. The ion spectra were
obtained by scanning from the 50 to 1100 m/z range. The
MassLynx V 4.1 (Waters Inc., USA) software was used for
data evaluation. The identities of the compounds presented in
each fraction were determined according to Bober et al.
(2011).
Toxicity assays
The dilution series of the aqueous crude extract and separated
fractions were prepared with appropriate exposure media in
the range of 0.1 to 10 mg d.w. mL−1. The evaluation of
cyanobacterial extract toxicity was performed through the ap-
plication of commercially available acute toxicity assays
based on the crustaceans Thamnocephalus platyurus
( T HAMNOTOXK I T F ) a n d D a p h n i a p u l e x
(DAPHNOTOXKIT F) following the respective standard op-
erational procedures (Microbiotests Inc., Belgium). The quan-
titative importance of the toxic effects was calculated as a 50%
effective concentration. Mortality (LC50) of T. platyurus lar-
vae was recorded after exposure to the cyanobacterial extract
for 24 h, whereas dead and immobile (EC50) D. pulex were
estimated after 24 and 48 h. In both assays, appropriate expo-
sure media were used as a control. The bioassays were con-
sidered valid if the mortality or immobilization of test organ-
isms in the controls did not exceed 10%. The toxicity of sep-
arated fractions was performed only against T. platyurus.
Enzyme inhibition assays
Detailed analysis of the toxicity mechanism used for the fol-
lowing enzymes, trypsin, chymotrypsin, elastase and throm-
bin, was performed only for the fraction, which gave a posi-
tive result in the crustaceans’ bioassays. This fraction was
dissolved in ethanol and then diluted in appropriate buffers
to perform the respective enzyme assays.
Trypsin inhibition assays
Inhibition assays of trypsin (EC 3.4.21.4) were performed
according to the modified method of Reshef and Carmeli
(2001). Trypsin was dissolved in 50 mM TRIS-HCl/
100 mM NaCl/1 mM CaCl2 pH 7.5 to prepare 1 mg mL
−1
solutions. This buffer was also used for the preparation of the
2 mM substrate solution of N-benzoyl-D,L-arginine-p-
nitroanilide. The reaction mixture, which contained 100 μL
of buffer, 10μL of enzyme solution and 10μL of test solution,
was added to a microtiter plate well and pre-incubated at 37 °C
for 5 min followed by the addition of 100 μL substrate solu-
tion. The absorbance of the solutions was measured immedi-
ately at 405 nm and after 30-min incubation at 37 °C.
Chymotrypsin inhibition assays
Inhibition assays of chymotrypsin (EC 3.4.21.1) were per-
formed according to the method of Kisugi and Okino
(2009). Briefly, chymotrypsin was dissolved in 50 mM
TRIS-HCl pH 7.6 to prepare a 15UmL−1 solution. This buffer
was used for the preparation of the 1 mg mL−1 substrate solu-
tion of N-succinyl-L-phenylalanyl-p-nitroanilide. The reaction
mixture, which contained 30 μL of buffer, 50 μL of enzyme
solution and 10 μL of test solution, was added to a microtiter
plate well and pre-incubated at 37 °C for 5 min, followed by
the addition of 100 μL substrate solution. The absorbance of
the solutions was measured immediately at 405 nm and after
30-min incubation at 37 °C.
Elastase inhibition assay
This inhibition assay was determined by modifying the meth-
od described by Grach-Pogrebinsky et al. (2003). The reaction
mixture, which contained 150 μL of 0.2 M TRIS-HCl buffer
(pH 8.0), 10 μL of elastase (EC 3.4.21.36) (0.0075 mg/mL in
0.2 M TRIS-HCl buffer (pH 8.0)) and 10 μL of test solution,
was added to eachmicrotiter plate well. Then, the mixture was
pre-incubated at 30 °C for 20 min, and 30 μL of N-succinyl-
Ala-Ala-Ala-p-nitroanilide (2 mM in 0.2 M TRIS-HCl buffer
(pH 8.0)) was added. The absorbance of the solutions was
read immediately at 405 nm and after incubation at 30 °C
for 30 min.
Thrombin inhibition assay
Thrombin (EC 3.4.21.5) inhibitory activity was measured ac-
cording to Anas (2012). Briefly, the reaction mixture, which
contained 90μL of thrombin from bovine plasma (1.3 UmL−1
in 0.15MTRIS-imidazole (pH 8.2)) and 20 μL of test sample,
was pre-incubated at 37 °C for 5 min. Then, 90 μL of Bz-Phe-
Val-Arg-pNa.HCl (200 μg mL−1 in 0.2 M TRIS-HCl buffer
(pH 8.0)) was added to begin the reaction. The absorbance
was measured immediately and after incubation at 37 °C for
30 min.
Chemicals
All reagents were analytical, HPLC or MS grade and were
from Sigma-Aldrich (USA) or delivered within crustacean
toxicity screening tests (Microbiotests Inc., Belgium).
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Ultrapure grade water (Milli-Q water) was obtained from
Millipore (USA).
Statistical analysis
Calculations of toxicity assays based on crustaceans were
made using probit analysis (U.S. EPA 1985). Briefly, the per-
centages of toxic effects were plotted against log concentra-
tion, and the 50% effective concentrations were calculated
using analysis of regression. Data obtained from enzyme as-
says were analysed using a sigmoidal dose-response curve and
BioDataFit 1.02 software (Chang Bioscience Inc.). All data
are expressed as the mean ± standard deviation (SD) of five
replicates.
Results
Toxicity of W. naegeliana cell extract
Among the test organisms, the greatest biological sensitivity
to the effect of the aqueous extract from W. naegeliana cells
was displayed by T. platyurus (Table 1). The denoted lethal
concentration on 50% of individuals after 24-h exposure to
cyanobacterial extract was 0.99 mg d.w. mL−1. The effective
concentration of 5.21 mg d.w. mL−1 caused death or immobi-
lization of D. pulex. However, two times longer exposure to
cyanobacterial extract (48 h) caused reduction of the effective
concentration by 1.77 times.
Toxicity of fractions
The extract obtained from W. naegeliana cells was separated
into 18 fractions (Fig. 1) that were used to determine which
secondary metabolites are responsible for the toxicity of
Table 1 Toxicity of the extract from Woronichinia naegeliana cells
assessed with crustaceans’ bioassays expressed as 50% effective
concentrations (LC50—mortality concentration; EC50—mobility










24 LC50 0.99 ± 0.25
Daphnia pulex 24 EC50 5.21 ± 0.38





































Fig. 1 Chromatogram of extract
obtained from Woronichinia
naegeliana cells monitored at
220 nm. Letters match the
fractions described in Table 2
Table 2 Percent of dead Thamnocephalus platyurus larvae exposed for
24 h to separate fractions extracted from 10 mg d.w. mL−1 Woronichinia
naegeliana cells. Data are expressed as mean ± SD (n = 5)






A Microginin FR3 9.2 100.0 ± 0.0
B Microginin FR4 10.7 14.0 ± 5.5
C Micropeptin T2 11.4 22.0 ± 8.4
D Micropeptin 478-B 12.3 16.0 ± 11.4
E Micropeptin 88D 12.8 30.0 ± 7.1
F Cyanopeptolin 880 13.6 20.0 ± 0.0
G Unknown compound 791 Da 17.0 24.0 ± 5.5
H Microginin 757 18.1 16.0 ± 5.5
I Cyanopeptolin 914, unknown
compound 874 Da
19.0 6.0 ± 5.5
J Unknown compounds—1013
and 973 Da
19.7 24.0 ± 8.9
K Micropeptin SD999, unknown
compound 1039 Da
20.4 22.0 ± 8.4
L Unknown compound 1047 Da 21.8 32.0 ± 4.5
M Microcystin-LR, microginin 91E,
planktopeptin BL1061,
unknown compound 1123 Da
23.1 26.0 ± 5.5
N Cyanopeptolin 908, oscillamide
B
24.0 10.0 ± 0.0
O Cyanopeptolin B, unknown
compound 888 Da
24.4 8.0 ± 4.5
P Cyanopeptolin C, unknown
compound 902 Da
27.2 40.0 ± 7.1
Q Microginin 51A, cyanopeptolin
D, unknown compounds—
1061, 1021 and 812 Da
28.2 8.0 ± 4.5
R Microginin 478 30.0 8.0 ± 4.5
a Fraction composition was determined according to Bober et al. 2011
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W. naegeliana. The bioactivity assays of separated fractions
were based on the crustacean T. platyurus that was found to be
more sensitive on cyanobacterial extract thanD. pulex. One of
the 18 fractions isolated from the cell extract exhibited biolog-
ical activity in the tested concentration range, and the deter-
mined LC50 was equal to its content extracted from
5.34 mg d.w. mL−1 W. naegeliana cells. The remaining frac-
tions containing secondary metabolites displayed a very low
or no toxicity making it impossible to determine the LC50
value (Table 2). The bioactive fraction A (Fig. 2) contained
pure microginin FR3 (MG-FR3) (purity 99%) for which de-
termined LC50 was equal to 7.78 μg mL
−1.
The enzyme inhibitory activity of MG-FR3
Protease assays including trypsin, chymotrypsin, elastase and

























Fig. 2 a Chromatogram of fraction A contained microginin FR3 monitored at 220 nm, b ion mass spectrum of microginin FR3 and cMS/MS product
ion spectrum of microginin FR3 (m/z 728.5 Da) inside the structure of microginin FR3
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positive result in bioassays with T. platyurus. The MG-FR3
did not affect the activity of tested enzymes (Table 3).
Discussion
Results showed different sensitivities of tested crustaceans to
aqueous extract fromW. naegeliana cells. A higher biological
response to cyanobacterial extract was observed for
T. platyurus rather than for D. pulex (Table 1). These results
are consistent with the findings ofMarsálek and Bláha (2004),
who found that T. platyurus revealed the highest sensitivity to
cyanobacterial samples among all tested commercially avail-
able biotests. A lower sensitivity to cyanobacterial extract was
observed for D. pulex, although its toxicity increased with
time.Woronichinia naegeliana has been described as a poten-
tial source of toxin by Scott (1991), but to the best of our
knowledge, there are no published quantitative data relating
to its toxicity. We compared our results with the values pre-
sented by Marsálek and Bláha (2004), who applied similar
bioassays in the assessment of Microcystis-dominated water
blooms. The determined toxicity of W. naegeliana cells was
classified as average (Table 4). In studies presenting data and
analyses of samples collected from blooms where
W. naegeliana was the dominant species among secondary
metabolites, different variants of microcystins have been de-
tected (Willame et al. 2005, Baudin et al. 2006). Although a
trace amount of microcystin-LR was also detected in the stud-
ied material, its toxicity values were higher than those obtain-
ed for M. aeruginosa cells containing a high amount of this
hepatotoxin. Additionally, the neurotoxicity of samples col-
lected from Finnish lakes was statistically associated with
the presence of Anabaena lemmermanni, Anabaena flos-
aquae and W. naegeliana cells in the samples (Sivonen et al.
1990). Neurotoxins were not detected in the studied
W. naegeliana cells. However, the possibility that the extrac-
tion procedure used and the conditions of the liquid chroma-
tography analyses were not optimal for the detection of the
neurotoxins cannot be excluded. The divergences in these
results might also be due to difficulties in the separation of
particular cyanobacterial species from the collected samples.
In the majority of the toxicity tests conducted for the sec-
ondary metabolites produced by W. naegeliana, their
Fig. 2 (continued)
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biological impact on T. platyurus has not been determined.
The exception is for microginin FR3 (Table 2). The difference
between the LC50 of separated fractions and that obtained for
the total W. naegeliana extract might be the result of the syn-
ergic effect of all the compounds. Most of the metabolites
synthesized by W. naegeliana (Bober et al. 2011, 2014) be-
long to several classes of oligopeptides, which non-ribosomal
synthesis is a significant part of cell metabolism (Welker and
von Döhren 2006). Although their ecological role has not
been fully elucidated, their inhibitory activity against prote-
ases indicates that they are able to affect other organisms, even
causing cell lysis. As a consequence, they might be a part of a
protection strategy in the aquatic ecosystem (see references in
Chlipala et al. 2011).
MG-FR3 belongs to the microginins, linear peptides that
contain four to six amino acid residues with a characteristic N-
terminal residue 3-amino-2-hydroxydecanoic acid (Ahda) and
frequently two tyrosine units at the C-terminus (Welker and
von Döhren 2006). Some of these oligopeptides have been
recognized as leucine aminopeptidase (LAP) inhibitors due
to the 2S configuration of the Ahda group (Ishida et al.
1997; Neumann et al. 1997). The structure N-Me-Tyr-Tyr at
the C-terminus seemed to be crucial for the inhibition of
angiotensin-converting enzyme (ACE) (Ishida et al. 2000).
The inhibitory activity of some microginins for ACE was
considered for the production of blood pressure-decreasing
drugs (Kraft et al. 2006). However, some microginins did
not show any inhibition activity against trypsin, chymotryp-
sin, papain, elastase or protein phosphatase 1A (Ishida et al.
1997).
MG-FR3, which was detected in the extract from
W. naegeliana cells, induced a biological response in crusta-
ceans and therefore was used in assays including digestive
proteases such as trypsin, chymotrypsin and elastase. The re-
sults are consistent with reports of other microginins showing
that MG-FR3 did not affect the activity of tested enzymes
(Table 3). No inhibition of thrombin was observed.
Therefore, the observed toxicity of W. naegeliana towards
planktonic invertebrates seems to be connected to a mode of
action other than serine protease inhibition or may be a result
of the synergic effect of all the produced cyanopeptides. To
date, the significance of these oligopeptides to cyanobacteria
metabolism and their biological function is unclear. There are
several hypotheses concerning cyanopeptides, including the
mechanism of the inhibition of vital enzymes, allelopathic
activity on other phytoplankton organisms, chemical grazing
protection and involvement in cell metabolism (see references
in Halstvedt et al. 2008). However, the modes of action re-
quire further investigation.
In conclusion, the biological activity of the poorly studied
freshwater bloom forming cyanobacteria W. naegeliana to-
wards planktonic invertebrates was studied. The biological
effects on planktonic crustaceans were related to a fraction
containingMG-FR3. Effective assessment of the environmen-
tal risk connected to the occurrence of cyanobacterial blooms
should also take into account others than those commonly
known to produce toxic secondary metabolites.
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